We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSH.L Regulatory News (NSH)

  • There is currently no data for NSH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

20 Aug 2020 10:30

RNS Number : 7099W
Norish PLC
20 August 2020
 

 

Norish plc

Interim results 2020

Results

 

Norish plc (AIM: NSH), is pleased to announce its interim results for the six months ended 30 June 2020.

 

Financial Highlights

· During the period the Group's balance sheet continued to strengthen

· Sales fell 9% from £17.5m to £15.9m

· Fully diluted adjusted EPS fell by 34%, year on year, from 3.1p to 2.06p

· Pre-IFRS 16 net debt reduced by £2m from £4.7m to £2.7m. Net debt after IFRS 16 adjustments reduced from Stg £9.7m at Dec-19 to Stg £7.7m at Jun-20. Cash availability amounts to £3m at June 2020.

· Interest cover pre IFRS 16 was 14.9 times.

 

 

Divisional Highlights

 

 

£'m

Cold Store

Sourcing

Dairy

 

Jun-20

Jun-19

% Growth

Jun-20

Jun-19

% Growth

Jun-20

Jun-19

% Growth

Revenue

7.1

7.3

(2.7%)

7.4

9.8

(24.5%)

0.4

0.4

Nil

Operating Profit

1.3

1.6

(19%)

0.1

0.2

(50%)

(0.1)

(0.1)

Nil

Operating Margin

18.3%

21.9%

 

1.4%

2.0%

 

(25%)

(25%)

 

 

 

Cold Stores

 

Sales in the temperature-controlled division declined 2.7%, a creditable performance given the considerable disruption to trade in both our cold store divisions, arising as a result of the Covid 19 pandemic. Overall profits declined by 19% reflecting the high fixed cost nature of the business.

 

Pallets into our cold stores, the life blood of our business, were particularly impacted as our end user market (China and foodservice) was neutered by covid 19, down 24%, year on year, in the period. Blast freezing volumes saw a reduction in activity from 65,220 pallets blast frozen to 59,351 pallets blast frozen. A second key metric, that of stock turn, again reflected the state of flux in the market, with average stock holding moving out from 6.6 weeks to 8.2 weeks. Pricing action offset these headwinds in significant part.

 

Like for like operational costs were cut to reflect lower activity levels but some new additional costs were incurred to minimise the risk of an outbreak of Covid 19 at our sites. Cold store profits declined by 6.4% in the South East, in the period under review, while profits declined by 22% in the North West.

 

 

 

Sourcing Division

 

Sales at our sourcing division declined by 14% in the first half of 2020, compared with the same period in 2019, from £9.8m to £8.4m. Operating profit declined by a corresponding 50%, year on year, from £0.2m to £0.1m, reflecting the impact of Covid 19 and tighter margins.

 

 

Dairy Division

 

Our investment in dairy is moving from the development to commercial phase. 

Our subsidiary, Grass to Milk Company, continues to execute to plan with its first A2 protein-based product in the final stages of development and an expected launch of this product, in high value export markets by the year end. The business has built considerable technical and commercial expertise to support a successful product launch and is engaging with a strong in-market commercial partner. We believe the business is well placed to add value to our unique grass-fed A2-protein milk supply. 

 

Cantwell's Court Farm's operating performance in the first half of 2020 was consistent with our expectations. Milk revenue was 3% ahead year on year, reflecting a 6% increase in volume driven by better production per cow and a 3% decline in pricing. Operating costs were ahead year-on-year reflecting lower than average pasture growth in the first half, initially due to a wet Spring followed by drought conditions in May and June. Our farming enterprise continues to improve incrementally across key operating KPIs, and our herd is now fully converted to A2 which will form the basis for our future A2-protein milk supply. 

 

The dairy divisions performance was impacted by incurring £0.1m in converting to an A2 herd.

 

Outlook

 

Our cold store business customer base substantially covers the UK Food Service and Chinese pork markets. Both markets were severely disrupted by Covid 19, resulting in customers converting stock to cash, in the first instance, in order to generate liquidity. This dynamic resulted in greater outflows of product, something we believe is necessarily transitory in nature.

 

Pricing in the Chinese pork market has recovered to a level which should sustain a strong export trade over the balance of the year, which will be positive for our North West division. In the South East, management have adapted our offering to reflect the current state of the British Food Service market, which is recovering in any event. We expect the profitability of our South Eastern division to be ahead of last year.

 

We are happy with the significant progress made with the development of our A2 protein milk supply via Cantwell's Court Farm. Grass to Milk Company remains on track to launch its first A2 protein-based product before year end, using our unique milk source.

 

The fallout in the UK Food Service market has afforded Town View Foods, our protein trading subsidiary, the opportunity to increase our trading network and rebuild our business. With an eye to opportunities post Brexit, we are now extending our footprint to South America on a minimal cost basis.

 

We believe our balance sheet strength affords us opportunity in the current environment, vis a vis many of our competitors in the sector.

 

Dividend

 

The board does not recommend the payment of an interim dividend, unchanged from last year.

 

 

 

 

Norish plc

 

 

 

 

 

 

 

Consolidated income statement

 

 

 

 

For the six months ended 30 June 2020

 

 

 

 

 

 

 

 

 

 

 

Six months

Six months

Year

 

 

ended

ended

ended

 

 

30 June

30 June

31 December

 

 

2020

2019

2019

 

 

(Unaudited)

(Unaudited)

(Audited

 

 

 

 

 

 

 

£'000

£'000

£'000

 

 

 

 

 

Continuing operations

 

 

 

 

Revenue

 

15,895

17,512

36,500

Cost of sales

 

(14,659)

(15,775)

(33,060)

Gross profit

 

1,236

1,737

3,440

 

 

 

 

 

Other income

 

88

70

107

Administrative expenses

 

(388)

(381)

(811)

 

Operating profit from continuing operations

 

936

1,426

2,736

 

 

 

 

 

Finance income - interest receivable

 

-

-

1

Finance expenses - interest on bank loans

 

(63)

(79)

(120)

Finance expenses - interest

 

(94)

(88)

(228)

 

 

 

 

 

Profit on continuing activities before taxation

 

779

1,259

2,388

 

 

 

 

 

Income taxes - Corporation tax

 

(160)

(311)

(247)

Income taxes - Deferred tax

 

-

-

(165)

 

 

 

 

 

Profit for the period attributable to owners of the parent from continuing operations

 

619

948

1,976

 

 

 

 

 

Loss from discontinued activities

 

-

(16)

(135)

 

 

 

 

 

Profit for the period

 

619

932

1,841

 

 

 

 

 

Other comprehensive income

 

-

-

-

 

 

 

 

 

Total comprehensive income for the year

 

619

932

1,841

 

Earnings per share expressed in pence per share:

 

 

 

 

From continuing operations

- basic

 

2.06p

3.1p

6.57p

- diluted

 

2.06p

3.1p

6.57p

From discontinued operations

- basic

 

0p

0p

(0.45)p

- diluted

 

0p

0p

(0.45)p

 

 

 

 

 

 

 

 

 

 

 

Norish plc

 

 

 

 

Interim balance sheet

 

 

 

 

As at 30 June 2020

 

 

 

 

 

As at

As at

As at

 

 

30 June

30 June

31 December

 

 

2020

2019

2019

 

 

(Unaudited)

(Restated)

(Audited)

 

 

 

 

 

 

 

£'000

£'000

£'000

 

ASSETS

 

 

 

 

Non-current assets

 

 

 

 

Goodwill

2,338

2,338

2,338

 

Intangible assets

807

332

564

 

Biological assets

700

674

824

 

Property, plant and equipment

22,592

22,436

22,777

 

 

26,437

25,780

26,503

 

Current assets

 

 

 

 

Trade and other receivables

4,838

6,230

6,857

 

Inventories

1,025

993

1,105

 

Cash and cash equivalents

1,501

973

1,054

 

Assets of disposal group classified as held for sale

277

284

277

 

 

7,641

8,480

9,293

 

 

 

 

 

 

TOTAL ASSETS

34,078

34,260

35,796

 

 

 

 

 

 

Equity attributable to equity holders of the parent

And non-controlling interest

 

 

 

 

Share capital

5,640

5,640

5,640

 

Share premium account

7,321

7,321

7,321

 

Other reserves

(21)

103

(21)

 

Treasury shares

-

(563)

-

 

Retained earnings

4,932

4,417

4,313

 

TOTAL EQUITY

17,872

16,918

17,253

 

 

Non-current liabilities

 

 

 

 

Borrowings

5,757

6,359

6,100

 

Deferred tax

1,002

816

1,002

 

 

6,759

7,175

7,102

 

 

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

5,526

4,993

6,564

 

Current tax liabilities

442

747

231

 

Borrowings

3,479

4,427

4,646

 

 

9,447

10,167

11,441

 

 

 

 

 

 

TOTAL EQUITY AND LIABILITIES

34,078

34,260

35,796

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Norish plc

Consolidated statement of changes in equity

For the six months ended 30 June 2020

 

 

 

 

 

 

 

 

 

 

 

 

Share

Share

Other

Treasury

Retained

 

 

 

 

 

capital

premium

Reserves

shares

earnings

Total

 

 

 

 

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

 

 

 

 

 

 

At 1 January 2019

5,640

7,321

103

(563)

3,485

15,986

 

 

 

 

 

 

 

 

 

 

 

 

 

Net profit for the financial period

-

-

-

 

932

932

 

 

 

Total comprehensive income for the period

-

-

-

-

932

932

 

 

 

Issue of share capital

-

-

-

-

-

-

 

 

 

Equity dividends paid (recognised directly in equity)

-

-

-

-

-

-

 

 

 

Treasury shares acquired

-

-

-

-

-

-

 

 

 

Transactions with owners

-

-

-

-

932

932

 

 

 

At 30 June 2019

5,640

7,321

103

(563)

4,417

16,918

 

 

 

 

 

 

 

 

 

 

 

 

 

Net profit/(loss) for the financial period

-

-

-

 

909

909

 

 

 

Total comprehensive income for the period

-

-

-

 

909

909

 

 

 

Issue of share capital

-

-

-

563

(563)

-

 

 

 

Equity dividends paid (recognised directly in equity)

-

-

-

 

(450)

(450)

 

 

 

Foreign Exchange gain

-

-

(124)

-

-

(124)

 

 

 

Transactions with owners

-

-

(124)

563

(104)

(335)

 

 

 

At 31 December 2019

5,640

7,321

(21)

 

-

4,313

17,253

 

 

 

                 

 

Net profit for the financial period

-

-

-

-

619

619

 

 

Total comprehensive income for the period

-

-

-

-

619

619

 

 

Issue of share capital

-

-

-

-

-

-

 

 

Equity dividends paid (recognised directly in equity)

-

-

-

-

-

-

 

 

Foreign Exchange gain

-

-

-

-

-

-

 

 

Transactions with owners

-

-

-

-

619

619

 

 

At 30 June 2020

5,640

7,321

(21)

 

-

4,932

17,872

 

 

 

 

 

 

Norish plc

 

 

 

 

Consolidated cash flow statement

 

 

 

For the six months ended 30 June 2020

 

 

 

 

Six months

Six months

Year

 

Ended

ended

Ended

 

30 June

30 June

31 December

 

2020

2019

2019

 

(Unaudited)

(Restated)

(Restated)

 

£'000

£'000

£'000

Profit on continuing activities before taxation

779

1,259

2,388

Gain on biological assets

(88)

(70)

(107)

Foreign exchange gain/(loss)

(51)

-

97

Loss on discontinued activities

-

(16)

(135)

Finance expenses

157

167

349

Finance income

-

-

(1)

Depreciation - property, plant and equipment

887

826

1,649

 

1,684

2,166

4,240

Changes in working capital:

 

 

 

Decrease /(increase) in inventories

80

(369)

(481)

Decrease/(increase) in trade and other receivables

2,019

20

(607)

Increase/(decrease) in trade and other receivables for disposal

-

40

47

Increase/(decrease) in current liabilities held for sale

-

(15)

(15)

(Decrease)/increase in payables

(1,038)

(453)

1,118

Cash generated from operations

2,745

1,389

4,302

 

 

 

 

Interest paid

(157)

(167)

(349)

Interest received

-

-

1

Taxation refund/(paid)

51

46

(406)

Net cash from operating activities

2,639

1,268

3,548

Investing activities

 

 

 

Investment in intangible assets

(243)

(166)

(419)

Purchase of biological assets

(5)

(4)

(1,734)

Sale of biological assets

268

39

209

Purchase of property, plant and equipment

(634)

(599)

(324)

Net cash used in investing activities

(614)

(730)

(2,268)

Financing activities

 

 

 

Dividends paid to shareholders

-

-

(449)

Invoice finance (payments)/receipts

(1,225)

(799)

(502)

Finance lease capital repayments

(405)

(514)

(979)

Finance lease advance

215

51

271

Term loan advance

-

314

300

Term loan repayments

(163)

(160)

(410)

Net cash used in financing activities

(1,578)

(1,108)

(1,769)

 

 

 

 

Net increase /(decrease) in cash and cash equivalents

447

(570)

(489)

 

Cash and cash equivalents, at beginning of period

1,054

1,543

1,543

 

 

 

 

Cash and cash equivalents end of period

1,501

973

1,054

 

Note: The accounting policies applied throughout the period are consistent with those applied for the year ended 31 December 2019, as set out in the 2019 Annual Report.

 

 

 

 

Enquiries:

Norish

 

Aidan Hughes, Finance Director

Telephone: + 44 1293 862 498

 

 

 

Davy

 

Anthony Farrell

Telephone: + 353 1 679 6363

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR GIGDICXDDGGG
Date   Source Headline
22nd Nov 20216:04 pmRNSChange of Name, Board and Management Changes
22nd Nov 202110:50 amRNSResult of EGM
1st Nov 20215:00 pmRNSNotice of EGM: Amendment to RNS
29th Oct 20214:25 pmRNSNotice of EGM
29th Oct 20214:23 pmRNSCompletion of Disposal of Cold Store Division
20th Oct 202112:49 pmRNSProposed Disposal of Cold Stores
8th Oct 20218:46 amRNSResult of AGM
30th Sep 202111:05 amRNSSecond Price Monitoring Extn
30th Sep 202111:00 amRNSPrice Monitoring Extension
30th Sep 20219:30 amRNSDisposal
15th Sep 20215:13 pmRNSNotice of AGM
4th Aug 20217:00 amRNSInterim Results 2021
1st Apr 202110:15 amRNSAnnual Financial Report
12th Mar 20217:00 amRNSPreliminary Results
11th Mar 202112:10 pmRNSConfirmation of Migration
18th Feb 20214:27 pmRNSEGM Results
22nd Jan 202112:45 pmRNSNotice of EGM
24th Aug 20209:39 amRNSCorrection - Half-year Report
20th Aug 20201:10 pmRNSResult of AGM
20th Aug 202010:30 amRNSHalf-year Report
24th Jul 20204:13 pmRNSNotice of AGM
8th Apr 202012:57 pmRNSAnnual Financial Report
1st Apr 202010:47 amRNSFurther Covid-19 Update
25th Mar 202010:33 amRNSCovid-19 - AGM and Dividend Update
13th Mar 20207:00 amRNSPreliminary Results
19th Nov 20195:49 pmRNSHolding(s) in Company
7th Nov 20195:33 pmRNSDirector/PDMR Shareholding
10th Oct 20191:06 pmRNSDirector/PDMR Shareholding
20th Sep 20197:00 amRNSHalf-year Report
8th Aug 20194:11 pmRNSHolding(s) in Company
23rd May 20193:18 pmRNSResult of AGM
23rd May 20199:25 amRNSTrading update ahead of AGM
2nd May 20194:57 pmRNSHolding(s) in Company
5th Apr 201910:15 amRNSAnnual Report and Notice of AGM
8th Mar 20197:00 amRNSPreliminary Results
21st Jan 20192:09 pmRNSHolding(s) in Company
23rd Oct 20182:12 pmRNSDirector/PDMR Shareholding
21st Sep 20181:49 pmRNSDirector/PDMR Shareholding
20th Sep 20187:00 amRNSHalf-year Report
23rd May 20181:55 pmRNSResult of AGM
23rd May 20187:00 amRNSTrading update ahead of AGM
26th Apr 20187:00 amRNSExercise of options and PDMR Notification
13th Apr 20187:00 amRNSAnnual Report and Notice of AGM
3rd Apr 201811:34 amRNSCompany Secretary Appointment
28th Mar 20187:00 amRNSPreliminary results
25th Oct 20179:48 amRNSDirector/PDMR Shareholding
14th Sep 20177:00 amRNSHalf-year Report
29th Jun 20172:44 pmRNSHolding(s) in Company
10th May 201711:22 amRNSResult of AGM
10th May 20177:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.